Global Amphotericin B Market, By Product Type (Static Drops, Atomization Inhalation, Local Lesion Injection, Other), Application (Vaginitis, Candida Infection, Leishmaniasis, Kala-Azar, Cryptococcal Infection, Aspergillus Infection, Other), Route of Administration (Intravenous, Parenteral, Oral, Other), Drug Class (Antifungals, Systemic, Other), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Global amphotericin B market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 12.00% in the above-mentioned forecast period.
Amphotericin B is a polyene antifungal antibiotic which is produced by Streptomyces nodosus. It is used for the treatment of fungal infections in neutropenic patients, cryptococcal meningitis in HIV infection, fungal infections, and leishmaniasis. It acts by stopping the growth of fungi as it binds to ergosterol (an important component of fungal membrane). It further causes depolarization of the membrane and altering cell membrane permeability which leads to leakage of important intracellular components, cell rupture, and results in cell death. It is given by injection into a vein.
Rise in the prevalence of fungal infections, emerging markets, rise in healthcare expenditure and growing government funds and initiatives for spreading awareness are the factors that will expand the global amphotericin B market.
Rising R&D activities and clinical trials will provide beneficial opportunities for the global amphotericin B market in the forecast period of 2021-2028.
Rise in the population that possess antifungal drug resistance and side effects of Amphotericin B such as blue lips, seizures, abdominal pain, numbness, fever, and other common effects are the factors that will hamper the market growth and will further challenge the global amphotericin B market in the forecast period mentioned above.
This Amphotericin B market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global amphotericin B market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Amphotericin B Market Scope and Market Size
The Amphotericin B market is segmented on the basis of product type, application, route of administration, drug class, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the amphotericin B market is segmented into static drops, atomization inhalation, local lesion injection, and other.
- On the basis of application, the amphotericin B market is segmented into vaginitis, candida infection, leishmaniasis, kala-azar, cryptococcal infection, aspergillus infection and other.
- On the basis of route of administration, the amphotericin B market is segmented into intravenous, parenteral, oral, and others.
- On the basis of drug class, the amphotericin B market is segmented into antifungals, systemic and other.
- On the basis of end-users, the amphotericin B market is segmented into clinic, hospital, and others.
- The amphotericin B market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Global Amphotericin B Market Country Level Analysis
Global amphotericin B market is analyzed, and market size information is provided by the country, product type, application, route of administration, drug class, end-users and distribution channel as referenced above.
The countries covered in the global amphotericin B market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the Amphotericin B market due to the presence of major key players, continuous technological development, well-developed healthcare sector, increasing prevalence of disease, and increasing awareness towards health in this region. Global amphotericin B market in the Asia-Pacific and Europe is expected to grow during the forecast period due to the increasing research and development activities, rising investment in the healthcare sector, and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Global amphotericin B market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Amphotericin B Market Share Analysis
Global amphotericin B market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global amphotericin B market.
The major players covered in the global amphotericin B market report are Bristol-Myers Squibb Company, MATINAS BIOPHARMA HOLDINGS, INC., Nano-X Imaging LTD., Nanomerics, DNDi, Abzena Ltd, Bharat Serums and Vaccines Limited (BSV), Astellas Pharma Inc., Leadiant Biosciences, Inc., Lilly, InterMune, Jina Pharmaceuticals, SteriMax, and XGen Pharmaceuticals DJB, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Amphotericin B Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.